+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Discovery AI"

From
Artificial Intelligence Market in Drug Discovery 2025-2029 - Product Thumbnail Image

Artificial Intelligence Market in Drug Discovery 2025-2029

  • Report
  • December 2024
  • 207 Pages
  • Global
From
From
From
Innovation Insights: AI in small molecule discovery - Product Thumbnail Image

Innovation Insights: AI in small molecule discovery

  • Report
  • January 2025
  • 48 Pages
  • Global
From
Innovation Insights: AI for drug target identification - Product Thumbnail Image

Innovation Insights: AI for drug target identification

  • Report
  • January 2025
  • 38 Pages
  • Global
From
From
From
From
From
Computer-Aided Drug Discovery Services Market, 2018-2030 - Product Thumbnail Image

Computer-Aided Drug Discovery Services Market, 2018-2030

  • Report
  • June 2018
  • 315 Pages
  • Global
From
Drug Discovery Services Market Report 2022-2032 - Product Thumbnail Image

Drug Discovery Services Market Report 2022-2032

  • Report
  • July 2022
  • 689 Pages
  • Global
From
From
Loading Indicator

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery. The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more